Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice
Kyeong Ok Kim
Clin Endosc 2022;55(4):480-488.   Published online 2022 Jul 28     DOI: https://doi.org/10.5946/ce.2022.108
Citations to this article as recorded by Crossref logo
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases
Boldizsár Jójárt, Tamás Resál, Diána Kata, Tünde Molnár, Péter Bacsur, Viktória Szabó, Árpád Varga, Kata Judit Szántó, Petra Pallagi, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas
Journal of Crohn's and Colitis.2024; 18(3): 392.     CrossRef
Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing
Markus F Neurath, Michael Vieth
Gut.2023; 72(11): 2164.     CrossRef
Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
Jill K J Gaidos, Badr Al Bawardy, Francis A Farraye, Miguel Regueiro
Crohn's & Colitis 360.2023;[Epub]     CrossRef
Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
Alina Ecaterina Jucan, Otilia Gavrilescu, Mihaela Dranga, Iolanda Valentina Popa, Ioana-Ruxandra Mihai, Vasile-Claudiu Mihai, Gabriela Stefanescu, Vasile Liviu Drug, Cristina Cijevschi Prelipcean, Radu-Alexandru Vulpoi, Oana-Bogdana Barboi, Irina Ciortesc
Biomedicines.2023; 11(11): 3090.     CrossRef
Active Assessment of Inflammatory Bowel Disease
金良 肖
Advances in Clinical Medicine.2022; 12(12): 11023.     CrossRef